Immuneering Corporation (IMRX)
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
$74.99M
Dr. Benjamin J. Zeskind M.B.A., MBA, Ph.D.
74.00
Cambridge, MA
Jul 30, 2021
-1.33
$-1.90
8.81
9.39
59.38%
-1.47
0.01
1.24
-0.87
9.39
-72.73%
-66.03%
Similar stocks (12)
Cullinan Oncology, Inc.
CGEM
Replimune Group, Inc.
REPL
Celcuity Inc.
CELC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Gossamer Bio, Inc.
GOSS
Nuvectis Pharma, Inc.
NVCT
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Kronos Bio, Inc.
KRON
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.0073%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Cullinan Oncology, Inc.
CGEM
Replimune Group, Inc.
REPL
Celcuity Inc.
CELC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Gossamer Bio, Inc.
GOSS
Nuvectis Pharma, Inc.
NVCT
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Kronos Bio, Inc.
KRON
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.0073%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%